Enteroscopy in Crohn’s Disease: Are There Any Changes in Role or Outcomes Over Time? A KASID Multicenter Study
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Background/Aims: Although balloon-assisted enteroscopy (BAE) enables endoscopic visualization of small bowel (SB) involvement in Crohn’s disease (CD), there is no data on the changes in outcomes over time. We therefore investigated the changes in BAE use on CD patients over different time periods in terms of its role and clinical outcomes. Methods: We used a multicenter enteroscopy database to identify CD patients with SB involvement who underwent BAE (131 procedures, 116 patients). We compared BAE-related factors and outcomes between the first period (70 procedures, 60 patients) and the second period (61 procedures, 56 patients). The specific cutoff point for dividing the two periods was 2007, when BAE guidelines were introduced. Results: Initial diagnosis of SB involvement in CD was the most common indication for BAE during each period (50.0% vs 31.1%, p=0.034). The largest change was in the number of BAE uses for stricture evaluation and/or treatment, which increased significantly in the latter period (2.9% vs 21.3%, p=0.002). The diagnostic yield in patients with suspected CD was 90.7% in the first period and 95.0% in the second (p=0.695). More endoscopic interventions were performed in the second period than in the first (5.1% vs 17.6%, p=0.041). Enteroscopic success rates were high throughout (100% in the first period vs 80.0% in the second period, p>0.999). In the first and second periods, therapeutic plans were adjusted in 62.7% and 61.4% of patients, respectively. Conclusions: The overall clinical indications, outcomes, and effectiveness of BAE were constant over time in CD patients with SB involvement, with the exception that the frequency of enteroscopic intervention increased remarkably.
Abstract
Background/Aims: Although balloon-assisted enteroscopy (BAE) enables endoscopic visualization of small bowel (SB) involvement in Crohn’s disease (CD), there is no data on the changes in outcomes over time. We therefore investigated the changes in BAE use on CD patients over different time periods in terms of its role and clinical outcomes. Methods: We used a multicenter enteroscopy database to identify CD patients with SB involvement who underwent BAE (131 procedures, 116 patients). We compared BAE-related factors and outcomes between the first period (70 procedures, 60 patients) and the second period (61 procedures, 56 patients). The specific cutoff point for dividing the two periods was 2007, when BAE guidelines were introduced. Results: Initial diagnosis of SB involvement in CD was the most common indication for BAE during each period (50.0% vs 31.1%, p=0.034). The largest change was in the number of BAE uses for stricture evaluation and/or treatment, which increased significantly in the latter period (2.9% vs 21.3%, p=0.002). The diagnostic yield in patients with suspected CD was 90.7% in the first period and 95.0% in the second (p=0.695). More endoscopic interventions were performed in the second period than in the first (5.1% vs 17.6%, p=0.041). Enteroscopic success rates were high throughout (100% in the first period vs 80.0% in the second period, p>0.999). In the first and second periods, therapeutic plans were adjusted in 62.7% and 61.4% of patients, respectively. Conclusions: The overall clinical indications, outcomes, and effectiveness of BAE were constant over time in CD patients with SB involvement, with the exception that the frequency of enteroscopic intervention increased remarkably.
참고문헌 (34)
- Hsu-Heng Yen, "Epidemiological trend in inflammatory bowel disease in Taiwan from 2001 to 2015: a nationwide population-based study", Intestinal research, 17(1), pp.54~62 (2019), 대한장연구학회[DOI]
- Choon Jin Ooi, "Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn’s disease in Asia", Intestinal research, 17(3), pp.285~310 (2019), 대한장연구학회[DOI]
- Masoud M Malekzadeh, "Iranian Registry of Crohn’s and Colitis: study profile of first nation-wide inflammatory bowel disease registry in Middle East", Intestinal research, 17(3), pp.330~339 (2019), 대한장연구학회[DOI]
- Gerson LB, "ACG clinical guideline : diagnosis and management of small bowel bleeding", Am J Gastroenterol, 110, pp.1265~1287 (2015)
- Papadakis KA, "Diagnostic approach to small bowel involvement in inflammatory bowel disease : view of the endoscopist", Dig Dis, 27, pp.476~481 (2009)
- Bourreille A, "Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease : an international OMED-ECCO consensus", Endoscopy, 41, pp.618~637 (2009)
- Lewis BS, "Expanding role of capsule endoscopy in inflammatory bowel disease", World J Gastroenterol, 14, pp.4137~4141 (2008)
- Leighton JA, "Role of capsule endoscopy in inflammatory bowel disease : where we are and where we are going", Inflamm Bowel Dis, 13, pp.331~337 (2007)
- Mikang Kim, "The role of small bowel endoscopy in small bowel Crohn’s disease: when and how?", Intestinal research, 14(3), pp.211~217 (2016), 대한장연구학회
- Akshay Pokala, "Update of endoscopic management of Crohn’s disease strictures", Intestinal research, 18(1), pp.1~10 (2020), 대한장연구학회
- Mensink PB, "Double-balloon enteroscopy in Crohn’s disease patients suspected of small bowel activity : findings and clinical impact", J Gastroenterol, 44, pp.271~276 (2009)
- Pohl J, "Diagnostic and therapeutic yield of push-and-pull enteroscopy for symptomatic small bowel Crohn’s disease strictures", Eur J Gastroenterol Hepatol, 19, pp.529~534 (2007)
- Sidhu R, "Guidelines on small bowel enteroscopy and capsule endoscopy in adults", Gut, 57, pp.125~136 (2008)
- Gerson LB, "Balloon-assisted enteroscopy : technology and troubleshooting", Gastrointest Endosc, 68, pp.1158~1167 (2008)
- Van Assche G, "The second European evidence-based consensus on the diagnosis and management of Crohn’s disease : definitions and diagnosis", J Crohns Colitis, 4, pp.7~27 (2010)
- Peyrin-Biroulet L, "Why should we define and target early Crohn’s disease?", Gastroenterol Hepatol (N Y), 7, pp.324~326 (2011)
- Satsangi J, "The Montreal classification of inflammatory bowel disease : controversies, consensus, and implications", Gut, 55, pp.749~753 (2006)
- 김용현, "Practice patterns and clinical significance of use of capsule endoscopy in suspected and established Crohn’s disease", Intestinal research, 15(4), pp.467~474 (2017), 대한장연구학회
- Gay GJ, "Enteroscopy in small intestinal inflammatory diseases", Gastrointest Endosc Clin N Am, 9, pp.115~123 (1999)
- Mehdizadeh S, "Capsule endoscopy in patients with Crohn’s disease : diagnostic yield and safety", Gastrointest Endosc, 71, pp.121~127 (2010)
- Jooyoung Lee, "Changes in Direct Healthcare Costs before and after the Diagnosis of Inflammatory Bowel Disease: A Nationwide Population-Based Study", Gut and Liver, 14(1), pp.89~99 (2020), 거트앤리버 소화기연관학회협의회
- Jeon SR, "Changes over time in indications, diagnostic yield, and clinical effects of double-balloon enteros-copy", Clin Gastroenterol Hepatol, 10, pp.1152~1156 (2012)
- Yang SK, "Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2005 : a KASID study", Inflamm Bowel Dis, 14, pp.542~549 (2008)
- Thia KT, "Risk factors associated with progression to intestinal complications of Crohn’s disease in a population-based cohort", Gastroenterology, 139, pp.1147~1155 (2010)
- Cosnes J, "Epidemiology and natural history of inflammatory bowel diseases", Gastroenterology, 140, pp.1785~1794 (2011)
- Manes G, "Use of double-balloon enteroscopy in the management of patients with Crohn’s disease : feasibility and diagnostic yield in a high-volume centre for inflammatory bowel disease", Surg Endosc, 23, pp.2790~2795 (2009)
- Rutgeerts P, "Predictability of the postoperative course of Crohn’s disease", Gastroenterology, 99, pp.956~963 (1990)
- Naganuma M, "Safety and usefulness of balloon endoscopy in Crohn’s disease patients with postoperative ileal lesions", J Crohns Colitis, 5, pp.73~74 (2011)
- Maaser C, "ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1 : initial diagnosis, monitoring of known IBD, detection of complications", J Crohns Colitis, 13, pp.144~164 (2019)
- Ohmiya N, "Small-bowel obstruction : diagnostic comparison between double-balloon endoscopy and fluoroscopic enteroclysis, and the outcome of enteroscopic treatment", Gastrointest Endosc, 69, pp.84~93 (2009)
- Gay G, "Double balloon enteroscopy in Crohn’s disease and related disorders : our experience", Gastrointest Endosc, 66(3 Suppl), pp.S82~S90 (2007)
- Heine GD, "Double-balloon enteroscopy : indications, diagnostic yield, and complications in a series of 275 patients with suspected small-bowel disease", Endoscopy, 38, pp.42~48 (2006)
- Jang HJ, "Clinical usefulness of double balloon enteroscopy in suspected Crohn’s disease : the KASID multi-center trial", Hepatogastroenterology, 61, pp.1292~1296 (2014)
- Rahman A, "Double-balloon enteroscopy in Crohn’s disease : findings and impact on management in a multicenter retrospective study", Gastrointest Endosc, 82, pp.102~107 (2015)